Additionally, the Kenneth team’s clinical research showed that miR-519c mimics inhibited the HuR/ABCG2 axis, increasing the sensitivity of 5-FU to 5-FU-resistant colon cancer cells (To et al., 2015). Here, ELAVL1 is linked to malignant colon neoplasm.